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Diet induced obesity (DIO), resulting from long-term consumption of a high fat diet, 
modifies multiple signaling pathways. These response pathways are closely associated with cell 
proliferation, inflammation and immune responses. The main goal of this present study is to 
investigate the impact from diet-induced obesity (DIO) on the regulation of expression of -
catenin and its localization, causing downstream impacts on cellular development, inflammation 
and immune system in the mouse colon.  
In this study, 5-week-old male mice were fed either a control diet (CON, 10% kcal from 
fat) or a high-fat diet (HF, 45% kcal from fat) for 11 weeks. Body fat percentage and food intake 
results indicate significant difference between two groups of mice. The effects of DIO on mRNA 
expression of related genes in selected pathways in the colon tissue were analyzed in both 
control and DIO mice. Wnt 2, Wnt5a, Wnt7b, Axin1, APC, CTNNB1 and c-Myc were 
significantly decreased while Sfrp2 and Sfrp 5 were significantly increased in DIO group, 
suggesting that Wnt signaling pathway were suppressed by DIO. The expression of p21 and Raf-
1 were also significantly decreased in DIO group, while Cyclin D1 was increased, suggesting 
that DIO has impact on cell proliferation. Immunofluorescent staining results suggested that 
repressed Wnt signaling prevented -catenin translocation and its nuclear accumulation, while 
Ki-67 showed a stronger signal intense in DIO mice.   
Overall, this study shows that DIO suppressed -catenin expression as well as nuclear 
accumulation, which inhibited Wnt signaling pathway while promoted cell proliferation in the 
colon of DIO mouse. Furthermore, findings from current study may be applied as colon health 
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Obesity and overweight, as previous research suggests, are most often caused by a lack of 
energy balance, which, in this case, means that the energy intake is greater than energy output. 
According to surveys conducted by the Centers of Disease Control and Prevention (CDC), which 
published by National Heart, Lung and Blood Institute (NIH) in 2012, more than 65% of adults 
in the U.S are considered to be overweight or obese and more than 30% of children (ages 2 to 
19) are considered to be either overweight or obese. Moreover, each year in the United States, 
obesity is involved in 400,000 deaths and costs $117 billion in health-care and related expenses 
(1). These statistics have no doubt raised obesity to one of the biggest public health concerns and 
challenges in this country, especially considering the associated risks of chronic diseases, 
including cancer development, linked with obesity. Diet-induced-obesity (DIO), as one of the 
most commonly studied topics among obesity related cases in animal experiments, has been 
tightly linked to several molecular and physiological dysfunctions including leptin resistance, 
glucose intolerance, oxidative stress promotion, ovarian morphology and eccentric hypertrophy 
(2-5). The mechanism behind these changes involves several important signaling pathways that 
have been discovered in human and animal models, including the upregulated inflammatory 
signaling pathway (inflammatory c-Jun N-terminal kinase and NF-kappa B signaling pathway), 
disrupted leptin signaling pathway, induced estrogen signaling (ER-independent E2-ERa) 
pathway, inhibited mTOR signaling pathway, impaired or inhibited AMPK and SREBP 
signaling pathway, and WNT signaling pathway (6-11). 
The Wingless/Integrase 1 (Wnt) signaling pathway, which is proved to be highly 
conserved in multicellular eukaryotic animals, plays an essential role in embryonic development 
and tissue homeostasis by regulating cellular processes such as proliferation apoptosis, 
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differentiation, polarization and motility (12-14). Furthermore, Wnt signaling is able to modulate 
various immune cell functions, including cytokine production, immune cell migration or 
differentiation, consequently shape inflammation and infection process and host response to 
pathogens (15-17). Three Wnt signaling cascades are included in Wnt signaling pathway: the 
Wnt/-catenin pathway (canonical), the -catenin independent Wnt/Ca2+ pathway, and 
Wnt/Planar cell polarity pathway (both non-canonical) (18). In canonical pathway, signals 
mostly go through GSK3, Axin1, APC or other set of cytoplasmic components to reach -
catenin and form a complex with TCF/LEF in the nucleus (19). This complex then triggers the 
expression of downstream target genes including c-Myc, VEGF and Cyclin D1, which regulates 
cell proliferation and angiogenesis (20-22). Non-canonical Wnt, on the other hand, can also 
regulate angiogenesis by targeting VEGE receptor Flt1 (also knowns as VEGFR1) (23), and cell-
proliferation, by binding to its receptor Ryk with Wnt5a (24, 25). Interestingly, many studies 
demonstrated that Wnt/-catenin pathway is a very important indicator during colorectal cancer 
(CRC) development, based on following reasons: a. muted Wnt/-catenin pathway was detected 
in approximately 90% of CRC cases (26); b. Wnt/-catenin signaling is proved to be essential for 
aberrant expansion of cancer stem/tumor-initiating cells (27); c. Wnt/-catenin signaling can 
induce the expression of epithelial mesenchymal transition (EMT) transcription factors, which 
contributes to the metastasis of CRC (28). 
Notably, -catenin from canonical Wnt signaling pathway plays a critical role in 
promoting proliferation and differentiation of stem cells in the intestinal crypts of epithelium. 
However, the mechanisms behind these regulations are not fully understood (29).  
The purpose of this present study is to investigate the role of DIO on the regulation of -
catenin expression and its impacts on other signaling pathways, which results in downstream 
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protein expression changes and differential responses triggered in epithelial cell development in 
the colon. We hypothesized that DIO would suppress -catenin expression, which leads to a 
downregulation of Wnt pathway target genes, such as c-Myc, and differential regulation of colon 
























High-Fat Diet (HFD) and Diet-Induced-Obesity (DIO) have been proved to play a 
significant role in regulating Wnt signaling pathway in several organs (or tissues) in animal 
model.  
SKELETAL DEVELOPMENT  
Research indicates that HFD and its consequence, DIO, can suppress Wnt/β-catenin in 
the bone of animal models. One study focusing on effects of high-fat diet on bone with male 
mice model has suggested that Non-Esterified Fatty Acids (NEFA) treatment depressed β-
catenin expression and activity in vitro, without causing effect on Wnt inhibitors such as DKK1, 
and it concluded that high fat diet can inhibit Wnt signaling and lead to less bone mass (30). 
Same discovery was claimed in one other study focusing on bone marrow adiposity and stromal 
cell differentiation. This study discovered that Wnt/β-catenin expression was significantly 
downregulated by HFD in bone of growing male rats (31). A more recent study focusing on bone 
acquisition in young male mice also concludes that DIO suppressed Wnt/β-catenin signaling can 
lead to less bone mass in male mice based on their observations (32). In Lu’s study, comparing 
to control group, gene expression of the key canonical Wnt signaling molecule, β-catenin, was 
found significantly downregulated in tibia bone collected from 8-week HFD treated male mice, 
confirmed by qPCR and western blot. To understand the mechanism through which Wnt/β-
catenin regulates bone formation and osteoblast function, Dr. Frey and her team conducted a 
study using C57BL/6 Lrp5 knockout and Lrp6 knockout male mice as animal model. In this 
study, Lrp5 was confirmed to be the coreceptor that stabilizes β-catenin in Wnt signaling 
pathway. With Lrp5 knockout, there were reduced osteoblasts and osteocytes exhibited in 
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postnatal bone mass, while body fat, including triglyceride and free fatty acids levels, increased 
in animal model. Therefore, the mechanism through which Wnt/β-catenin alters bone mass and 
body composition proposed by the author is: Wnt/β-catenin signaling regulates bone formation 
and fatty acid metabolism in animal model by binding with coreceptor Lrp5, rather than Lrp6, 
which further reallocates fuel sources and alters body composition (33). 
 
ADIPOGENESIS PROGRAMMING  
HFD and DIO were also observed to suppress Wnt/β-catenin signaling pathway in 
adipose tissue of animal model.  One study suggests that the expression of several genes 
involved in canonical Wnt signaling pathway (Wnt1 and Wnt3a) was downregulated with HFD 
treatment after 63 days in subcutaneous adipose tissues in rats, as well as the Wnt ligands Wnt1, 
Wnt3a and Wnt10b, which were all downregulated in both subcutaneous and epidydimal adipose 
tissue (AT) significantly (P < 0.05) at 63 d of experiment. Furthermore, it found that canonical 
Wnt receptors such as Fzd1, Fzd2 and Fzd5 was all lowered significantly (P < 0.05) in AT with 
initiation of HFD at 63 d. Wnt signaling intermediates, GSK3β and β-catenin, was also found 
lower in epidydimal adipose tissue with HFD at 63d, while no difference in expression was 
observed in subcutaneous AT (34). Consistent with their observations, a recent published study 
also found that early stage of obesity model significantly downregulates β-catenin mRNA 
expression (P < 0.05). This study also performed western blot to confirm the change of β-catenin 
expression on protein level, which was also decreased with obesity model, in the adipose tissue 
of male Sprague-Dawley rats. Furthermore, this study discovered that the expression of 
canonical Wnt signaling players (Wnt3a) was also downregulated in obese rat model, while 
wnt5a, a member of non-canonical Wnt signaling pathway, was significantly upregulated. 
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Together, the author summarized that early stage of obesity may affect cell proliferation and 
regulate adipogenesis through Wnt/β-catenin signaling pathway as well as non-canonical Wnt 
signaling, limiting the hyperplasia of adipocytes in animal model (35). A potential mechanism 
through which Wnt/β-catenin regulates adipogenesis programming, discovered by Dr. Chen in 
2015, is through the regulation of its effector transcription factor 7-like-2 (TCF7L2). TCF7L2 is 
a component in Wnt signaling pathway and is commonly connected with diabetes and other 
metabolic disorders. In HFD fed mice, epidydimal fat TCF7L2 mRNA level was found lower 
than control diet fed mice, which is corresponding to the downregulated Wnt/β-catenin signaling 
pathway (36). Although the role TCF7L2 plays in adipocytes development remains unknow as 
recently published study points out, it is clear that TCF7L2 is crucial for maintaining the normal 
function of adipocytes and regulating adipogenesis, while downregulation of TCF7L2 could 




HFD and DIO have been proved to affect hepatic function significantly by regulating 
multiple signaling pathways, including both canonical and non-canonical Wnt signaling 
pathways, and may contribute to the development of certain diseases such as liver steatosis and 
fibrosis, even cancer. To investigate the roles of Wnt/β-catenin signaling pathway in regulating 
hepatic fat accumulation, one study measured β-catenin protein level in the liver of obese rats 
and found that obesity significantly downregulates β-catenin protein level compared to lean 
group, indicating an inhibited canonical Wnt signaling pathway in liver. This consequently leads 
to an overall increase in hepatic fat and affect liver functions, increasing risk of steatohepatitis 
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and further hepatocarcinogenesis (38). Another study, aiming to clarify the role of β-catenin in 
mouse liver fibrosis, found that hepatic β-catenin regulates systemic energy homeostasis through 
hepatic fatty acid oxidation, ketogenesis and mitochondrial functions, and therefore affects the 
development of DIO. The author concluded that β-catenin may be the key player in the 
pathogenesis of fatty liver disease, DIO and insulin resistance (39). Besides canonical Wnt 
signaling pathway, β-catenin is also found to interact with other signaling pathway to affect liver 
function. In Zhai’s study, β-catenin reduces mRNA expression and activity level of sterol 
regulatory element-binding protein-1c (SREBP-1c) in mouse liver, which can inhibit hepatic 
stellate cells (HSCs) activation, a key step in hepatic fibrogenesis. Because SREBP-1c 
expression plays important role in leptin regulation, and leptin induced liver fibrosis in mice, the 
author believe that this is a potential mechanism for β-catenin to contribute to liver fibrogenesis 
(40). In conclusion, because of the complexity of Wnt/β-catenin signaling in liver, the 
mechanism through which this pathway regulate hepatic function and disease development 
remains unclear based on current literature, however, it is evident that Wnt/β-catenin signaling is 
downregulated by DIO in liver and this downregulation is connected with various DIO related 
liver diseases including insulin resistance, leptin regulation, liver fibrosis and 
hepatocarcinogenesis. 
 
ENERGY METABOLISM AND GLUCOSE HOMEOSTASIS 
Besides glucose intolerance and insulin resistance altered by Wnt/β-catenin in adipocytes 
and liver, recent work also highlights that Wnt signaling plays critical role in the neuroendocrine 
control of glucose and energy metabolism. In a research conducted using C57BL/6JRj male 
mice, a significantly downregulated expression of the ligands Wnt7a (P = 0.004) and Wnt4 
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(P=0.038) was found in the hypothalamic arcuate nucleus (ARC) of leptin-deficient obese mice, 
in comparison with the expression in control wild type mice. The mRNA expression of Wnt 
signaling downstream target genes Axin-2 (P=0.002) and CyclinD1 (P=0.043) in the 
hypothalamic arcuate nucleus (ARC) of leptin-deficient obese mice was also found 
downregulated significantly. The observations support the conclusion that hypothalamic Wnt 
signaling is impaired during obesity, which is crucial for high-fat diet-induced weight gain as 
well as glucose homeostasis (41). 
Wnt/β-catenin signaling was also found to be associated with susceptibility to type 2 
diabetes by altering β-cell proliferation and total mass in the pancreas. In Dr. Elghazi’s study 
published in 2012, the author observed that with β-catenin deletion, mature β-cell proliferation 
and mass were impaired in adult male mice, which alters glucose homeostasis in the animal 
model. Besides, abnormal insulin sensitivity was also discovered after depletion of β-catenin, 
which might be caused by the increased motor activity in the basal state of mice. Although how 
Wnt/β-catenin signaling pathway alters different tissue to control glucose and insulin sensitivity 
is not completely understood yet as the author suggests, it is clear that this signaling pathway 
play important role in pancreas, especially for insulin secretion and function, and this could be 
another mechanism HFD/DIO affect glucose homeostasis in animal model (42). 
 
KIDNEY FUNCTION 
Although the studies mentioned above all observed down-regulated Wnt signaling 
pathway in different organs using animal models, either canonical or non-canonical, during high-
fat-diet treatment or by obesity, HFD/DIO was also found to upregulate Wnt/β-catenin in 
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specific tissue. For example, one study conducted using male C57/BJ mice found that mRNA 
expression of genes involved in Wnt signaling, Wnt1 and Wnt16, were upregulated in the kidney 
of HFD mice group comparing the control group. Despite the fact that the mechanism behind this 
observation remains unclear and it requires further investigation to be fully established, this 
study indicates that HFD regulated Wnt signaling pathway can be further linked to lipid transport 
and metabolism related to kidney function (43). 
 
EARLY LIFE PROGRAMMING 
Few studies have done focusing on HFD-mediated β-catenin expression in placenta of 
animal model. In Dr. Strakovsky’s study published in 2012, Wnt/β-catenin signaling inhibitor 
Dickkopf homolog 1 (Xenopus laevis) (DKK1) mRNA expression was found significantly 
lowered in placentas of obesity prone (OP) rats fed with HFD. Meanwhile, nuclear β-catenin 
protein expression was significantly increased in OP rat placentas comparing to obesity 
resistance (OR) rats. Therefore, the author concluded that Wnt/β-catenin signaling pathway is 
dysregulated in the placenta of obese rats and is directly involved in placental lipid metabolism: 
Aberrant Wnt/β-catenin with decreased DKK1 expression leads to less decidual/junctional 
thickness of placenta and consequently decreased placental efficiency (44). The author also 
proposed that this activation of Wnt/β-catenin signaling may trigger the expression of Ppard, a 
potent inducer of adipogenesis and lipogenesis, which could serve as a signal between mother 






Previous studies suggest that DIO is tightly connected to colon carcinogenesis. As a 
prospective cohort study has reported, obesity, caused by high energy and high fat intake, was 
associated with increased risk of colon cancer development as well as increased death rate (45, 
46). A recently published review article utilizing next generation RNA sequencing concluded 
that DIO (caused by HFD) stimulates multiple pathways involved in inflammation (i.e. IL-6, IL-
8 and dendritic cell and leukocyte signaling) and tumorigenesis in mouse colon (i.e. eNOS 
signaling and VEGF signaling), which are similar to those found in human colon cancer with 
inflammatory microsatellite instability (47). Wnt/β-catenin signaling pathway, among all the 
pathways altered by DIO in colon, is generally believed to be elevated after long-term 
consumption of high fat diet in animal model, while the mutation of transcription factor β-
catenin is commonly believed to be a key player in the development of CRC. In a recent 
published study, upregulation of β-catenin gene and protein expression were detected in colon 
epithelium in male Wistar rats fed HFD for 17 weeks. This study failed to illustrate the detailed 
mechanisms through which HFD regulate β-catenin expression, and to demonstrate any 
downstream regulation involved in CRC development that is caused by the change of β-catenin 
expression directly. However, the authors concluded that HFD-mediated tumorigenesis in colon 
is associated with increased cell cycle progression as well as the inflammation responses 
triggered by the upregulation of β-catenin. Furthermore, this study suggests that HFD not only 
increases β-catenin expression, but also NF-κB, another transcription factor that is responsible 
for inflammation responses and regulation of cyclin D1 and COX-2 expression (48). On the 
other hand, an earlier published study proposed another mechanism, through which β-catenin 
regulates NF-κB expression in opposite direction: in this study, β-catenin was found to 
11 
 
physically complex with NF-κB, which reduces NF-κB DNA binding capability, therefore 
decreased its transactivation activity and ultimately its target gene expression.  The author 
concluded that β-catenin can inhibit NF-κB activity and repress the expression of Fas, a NF-κB 
target gene. Fas is a cell surface receptor in tumor necrosis factor receptor (TNFR) family, it is 
expressed in normal epithelial cells to mediate apoptosis and is usually downregulated in colon 
carcinomas. Because β-catenin is an inhibitor of NF-κB, while Fas-induced apoptosis requires 
NF-κB, the activation of β-catenin therefore contributes to the oncogenesis in both human colon 
and human breast cancer cell lines (49).  
In summary, DIO from HFD was observed in several cases to activate Wnt/β-catenin 
signaling pathway in colon, which further triggers inflammation responses through other 
signaling pathways such as NF-κB and regulate colon epithelial cell proliferation as well. 
Aberrant Wnt/ β-catenin activity in colon therefore is considered as a biomarker for colon 
carcinogenesis. However, most of these studies are done using azoxymethane treated animal 
model rather than healthy animals, thus it remains unclear how DIO alters Wnt/β-catenin 











ANIMAL AND DIETS 
Male CBA mice (The Jackson Laboratory) were purchased at 4 weeks of age and were 
accommodated in standard polycarbonate cages (4 mice per cage) at a humidity-and temperature-
controlled room at Edward R. Madigan Laboratory for one week prior to experiment in order to 
acclimatize. At 5 weeks of age, male mice were divided into control diet (CON; n=12) or higher-
energy-density diet (DIO; n=14). Both groups were provided food and water ad libitum and 
maintained at a 12-hour light condition. Following 11 weeks of the dietary intervention, mice in 
each diet group were sacrificed by CO2 asphyxiation, colon tissue samples from each mouse 
were collected. All procedures were approved by the Institutional Animal Care and Use 
Committee at the University of Illinois at Urbana-Champaign. 
Mice in the DIO group were provided a high energy dense diet containing 4.73 kCal/g, 
consisting of 20% (kCal%) protein, 35% carbohydrates and 45% fat (D12451i, Research Diet 
Inc.), for 10 weeks to induce obesity (DIO). Meanwhile, mice treated with control diet were 
provided a diet containing 3.85 kCal/g, consisting of 20% (kCal%) protein, 70% carbohydrates 
and 10% fat (D12450Hi, Research Diet Inc.) for 10 weeks. The formula of higher-energy-density 
diet was modified using lard as the major source of energy, while control diet used corn starch. 
(Supplementary Table 1).   
CBA mouse strain is often used in research fields such as immunology, oncology and 
pharmacology. The CBA has life-span going from 69 up to 117 weeks, depending on sex. 
Previous study used CBA mouse to investigate the effects of thalidomide on colorectal cancer 
liver metastases (50). Besides, the male CBA is recommended (The Jackson Laboratory) to be 
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applied for diabetes and obesity research, particularly, for obesity-induced insulin resistance 
(51), maturity-onset diabetes-obesity syndrome (52) and hearing loss resulting from high-fat-
diet-induced type 2 diabetes (53). Because CBA has been proved to be susceptible to diet-
induced-obesity and shows steady growth rate with high fat diet, it is selected to conduct the 
current study. 
Food intake data of every cage was recorded weekly during experiment period, while 
magnetic resonance imaging (MRI) was conducted monthly. Behavioral changes and stress 
responses, such as hair loss, were monitored daily. 
 
COLON TISSUE SAMPLING 
After 10 weeks of feeding, mice from both diet groups with sedentary treatment were 
randomly selected and killed by CO2 asphyxiation. The entire colon was immediately and 
carefully removed and divided to proximal and distal half equally, by measuring the length from 
cecal junction to rectal junction. Both proximal and distal colon sampled were immediately 
dipped in cold (cooled by liquid nitrogen) 2-methylbutane (Thermo Fisher Scientific, Waltham, 
MA) until completely frozen, then stored using aluminum foil labeled on it in -80 C freezer for 
further experiments and histological analysis. 
 
QUANTITATIVE RT-PCR 
Scraped proximal colon tissues (40-50 mg per animal) were grounded using liquid 
nitrogen and treated with TRIzol Reagent (Thermo Fisher Scientific, Waltham, MA). Total RNA 
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was isolated according to the manufacturer’s instructions (ZYMO RESEARCH CORP.) using 
Direct-zol RNA MiniPrep Plus Kit (ZYMO RESEARCH CORP). RNA concentrations were 
measured by a Spectrophotometer (NanoDrop 2000, Thermo Fisher Scientific, Waltham, MA). 
cDNA was synthesized from RNA using the High Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems, Foster City, CA) in a Thermal Cycler 2720 (Applied Biosystems). In each 
reaction system, 1000 ng (with concentration of 100 ng/μL) of total RNA were added in 10 μL 
mixture containing 2 μL 10× RT buffer, 0.8μL 100mM dNTPs, 2 μL 10× RT random primers, 1 
μL 50U/μL MultiScribe Reverse Transcriptase and 4.2 μL Nuclease-free H2O. cDNA synthesis 
was performed using the following program: 25 C for 10 minutes, 37 C for 2 hours, and 85 C 
for 5 seconds. Synthesized cDNA was then analyzed by PCR in StepOnePlus Real-time q-PCR 
system (Applied Biosystems).  In each reaction, 5 ng of synthesized cDNA was used in a 10 L 
volume containing 5 L of Quanta PerfecTa SyBR Green FastMix ROX (2x, Quantabio), 0.4 L 
of foward primer (5 M), 0.4 L of reverse primer (5 M) and 2.2 L Nuclease-free H2O. q-
PCR was performed using the following program:  95 C for 10 minutes, followed by 45-50 
cycles of 95 C for 15 seconds and 60 C for 1 minute.  After q-PCR, melting curves were 
acquired stepwise from 55 to 95 C to ensure that a single product was amplified in the reaction.  
Reference genes L7a, GAPDH and β-Actin were used as internal controls for result 
normalization. Gene expression quantity gained during q-PCR was analyzed and generated by 
StepOne Software v2.3 (Applied Biosystems). The primers used in this study are listed in the 






Unfixed, frozen colon samples were embedded in Tissue-Tek OCT compound (VWR, 
Radnor, PA) prior to sectioning and cut to 14 µm thickness using a Leica CM3050 S cryostat 
(Leica Microsystems, Inc., IL) -20 °C. After sectioning, OCT was removed from sections by 
washing with 1X PBS and double distilled water, sections were then fixed in 70% ethanol and 
stained with hematoxylin (Thermo Fisher Scientific, Waltham, MA) and eosin (Thermo Fisher 
Scientific, Waltham, MA)) for histological analysis. Slides were scanned using Nanozoomer 
Digital Pathology system with magnification of 20X (Hamamatsu Photonics, K.K., Japan), 6 
animals from each group, three 350 μm x 350 μm blocks from each animal were randomly 
selected to do image analysis. Image analysis was performed by Image J software (Rasband, 
W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://imagej.nih.gov/ij/, 1997-2017).  
 
IMMUNOFLUORESCENT STAINING 
Slides with unfixed, frozen colon were embedded in Tissue-Tek OCT compound (VWR, 
Radnor, PA) and cut to 14 µm thickness sections using Leica CM3050 S cryostat (Leica 
Microsystems, Inc., IL) at -20 °C, sections were stored in -80 °C before immunofluorescence. 
When conduct immunofluorescent staining, slides were first washed in 1X PBS and fixed in 4% 
formaldehyde. Then, slides were blocked with blocking buffer (1X PBS/5% normal goat 
serum/0.05% Triton X-100) and incubated with 1) primary antibody β-Catenin (D10A8) XP® 
Rabbit mAb (1:100 dilution, Cell Signaling Technology, Danvers, MA) at 4 °C overnight. After 
primary incubation, slides were washed again with 1X PBS and then incubated with Anti-rabbit 
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IgG (H+L), F(ab')2 Fragment (Alexa Fluor® 488 Conjugate) secondary antibody (1:100 dilution, 
Cell Signaling Technology, Danvers, MA) at room temperature for one hour; 2) primary 
antibody Alexa Fluor® 488 anti-mouse/human Ki-67 (1:100 dilution, BioLegend, San Diego, 
CA). After primary and secondary incubation, all slides were rinsed in 1X PBS again and 
incubated with DyLight 554 Phallioidin (1:50 dilution, Cell Signaling Technology, Danvers, 
MA) and DRAQ5 (1:100 dilution, Cell Signaling Technology, Danvers, MA) for 15 minutes in 
dark at room temperature. After incubation, slides were washed with 1X PBS, mounted with 
Prolong-Gold Antifade Reagent (Molecular Probes by Life Technologies, Carlsbad, CA) and 
dried in dark overnight at 4 C. Pictures were taken using the Confocal LSM 700 microscope 
(Carl Zeiss Microscopy, LLC, United States) with magnification of 20X and 63X Oil for slides 
stained with β-Catenin, and LSM 880 microscope (Carl Zeiss Microscopy, LLC, United States) 
with 20X magnification for slides stained with Ki-67. Pictures were acquired using Zen software 
(Carl Zeiss AG, Ontario, CA). 
 
-CATENIN LOCOLIZATION AND QUANTIFICATION 
The localization and quantification of -catenin were determined using pictures gained 
from immunofluorescent staining. To determine the nucleus -catenin accumulation in colon 
cells, data were obtained using 22 randomly selected colon cells at same location (top part of 
crypt where interfacing lumen) in one animal from each group. Imaris Software (Bitplane AG, 
Zurich, Switzerland) was applied to separate the nucleus by surface and measure the signal 
intensity of stained nucleus -catenin protein within each nucleus. Final results are presented as 
the mean signal intensity ratio to nucleus volume (µm3) ± SEM. 
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KI-67 LOCALIZATION AND QUANTIFICATION 
The localization and quantification of Ki-67 were determined using pictures gained from 
immunofluorescent staining. To quantify Ki-67 signal intensity in colon cells, five 50 µm x 50 
µm areas were selected from one captured picture in one animal from each group. ImageJ 
Software (NIH, Bethesda, MD) was applied to separate the nucleus and Ki-67 signal by channel 
and to measure the signal area of stained Ki-67 and nucleus. Final results are presented as the 
mean Ki-67 signal area ratio (µm2) to nucleus signal area (µm2) ± STD. 
 
STATISTICAL ANALYSIS 
Differences in body weight and food intake between groups were analyzed using 
repeated-measures one-way ANOVA and Tukey HSD test (RStudio, Version 1.0.136, Library 
“stats”, Inc., Boston, MA). Results were reported as means ± SEM. Differences between two 
animal groups were considered significant at P<0.05.  
Results from MRI data, quantitative real-time PCR analysis and immunofluorescence 
quantification analysis were analyzed using two-tailed t-test ((Data Analysis, Microsoft Office 
Excel 2016). Results were reported as means ± SEM. Differences between two diet groups were 









11-WEEK OF HIGHER ENERGY DENSITY DIET INDUCED SIGNIFICANT 
CHANGES ON BODY WEIGHT AND BODY FAT COMPOSITION OF MICE AND 
SUCCESSFULLY CAUSED DIO 
All mice survived the full treatment period, no mice were observed to have behavioral 
changes or stress responses. There was no significant difference in body weight (P = 0.24) and 
body fat percentage (P = 0.76) when the animal trial was started (data was measured at the first 
week of experiment). There was significant difference in body weight between the DIO and 
CON groups during the trial (P<0.0001, Figure 1A) and in average daily energy intake (kCal) 
per mouse throughout the trial (CON, 11.73±0.25 kCal/mouse/day; DIO, 13.78±0.27 
kCal/mouse/day; P = 0.0002, Figure 1B). Significant difference in fat mass (P<0.0001) and body 
fat percentage (P<0.0001) between the two dietary groups was also observed, according to the 
MRI data collected at week 5 and week 9 (Figure 1C). 
At the end of the treatment period, the body fat percentage (%) observed in mice fed 
higher-energy-density diet was 34.84 ± 0.96 compared to 25.33 ± 0.84 in control group, which is 
considered high enough to define the mice fed with higher-energy-density diet as “diet-induced-
obesity” and matches the “fat-tissue-percent” data provided by The Jackson Laboratory for its 
DIO mouse model.  
 
HISTOLOGY ANALYSIS SUGGESTS NO SIGNIFICANT DIFFERENCE ON 
HISTOLOGICAL STRUCTURE BETWEEN DIO MICE AND CONTROL MICE 
Examined by hematoxylin and eosin (H&E) staining (n=6 in each group, three 350 μm x 
350 μm image block in each animal), no significant difference was observed in the aspect of 
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histological structures, particularly, the average length of the crypt was not affected by DIO. 
(Figure 2).  
 
DIO SUPPRESSED MRNA EXPRESSION OF GENES INVOLVED IN BOTH 
CANONICAL AND NON-CANONICAL WNT SIGNALING PATHWAY  
To investigate the possible mechanism through which diet-induced-obesity regulates Wnt 
signaling pathway, the expression of genes/proteins involved in Wnt signaling were tested by 
RT-PCR of the colon sections from both groups of mice. In general, higher-energy-density diet 
and consequently diet-induced obesity affected the expression of Wnt5a in non-canonical Wnt 
pathway, Wnt7b, Wnt2, Axin1, APC, Sfrp2 and Sfrp5 in canonical Wnt pathway. Particularly, 
DIO also affected the mRNA expression of CTNNB1, which codes -catenin, the most important 
player in Wnt signaling, and c-Myc, the downstream target genes of Wnt signaling. Notably, DIO 
downregulated the mRNA expression levels of Wnt2, Wnt5a (p < 0.05), Wnt7b (p < 0.05), 
CTNNB1 (p < 0.05), Axin1 (p < 0.05), APC and c-Myc (p < 0.05) while upregulated expression 
levels of Sfrp2 (p < 0.05) and Sfrp5 (p < 0.05) (Table 1).  
 
GENES REGULATING CELL CYCLE REGULATED BY WNT SIGNALING 
EXPRESSED DIFFERENTLY BETWEEN TWO DIET GROUPS 
As previously mentioned, Wnt signaling plays significant role in cell development and is 
able to mediate inflammation and immune responses by targeting or binding to different 
receptors. Therefore, it is reasonable to assume that the mRNA expression of genes related to 
these processes could be affected by suppressed Wnt signaling due to diet-induced obesity. To 
examine this assumption, mRNA expressions of selected genes were tested by RT-qPCR of the 
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colon sections from both groups of mice. These following genes mRNA expression was found to 
be different between control and DIO mice: p21, Raf-1, CyclinD1. Notably, DIO significantly 
downregulated the mRNA expression levels of p21 (p < 0.05), Raf-1 (p < 0.05), while 
significantly upregulated expression levels of CyclinD1 (Table 1).  
 
DIO LOWERED GENERAL ACCUMULATION OF -CATENIN AND INDUCED 
DIFFERENT EXPRESSION LEVEL OF -CATENIN ALONG THE COLONIC CRYPT 
The regulation of Wnt/-catenin signaling was examined by conducting immunofluorescent 
staining using -catenin antibody). Specifically, a change of localization of -catenin 
accumulation was observed during the analysis of immunofluorescent pictures between DIO 
mice and control group. Along the distal colonic crypt, with a magnification of 20X (Figure 3 A-
H), we discovered that mice in DIO group have, in general, a decreased accumulation of -
catenin in the epithelia, when comparing to the control group.  This decrease is more profound at 
the simple columnar epithelium (the top of the crypt near lumen) where most cells are absorptive 
columnar cells, and at the submucosa tissue. Within the colon of the DIO mice there is a visibly 
higher -catenin accumulation at the bottom part of crypt near the submucosa, where stem and 
progenitor cells are housed. Furthermore, with a magnification of 63X Oil (Figure 3 I-P), a 
significant diet effect on the nuclear accumulation of -catenin protein between DIO mice and 
mice in the control group was found, which is consistent with the mRNA expression result: DIO 
mice have a lower nuclear accumulation of -catenin protein comparing to control group (Figure 




DIO INDUCED HIGHER EXPRESSION OF CELL PROLIFERATION MARKER KI-67 
IN COLON OF MICE 
To further investigate the effect of downregulated -catenin expression on cell 
proliferation in colon of mouse, immunofluorescent staining using Ki-67 antibody was 
performed. With a magnification of 20X, a significant diet effect on the signal intensity of Ki-67 
protein between DIO mice and CON mice was observed (Figure 4 A-H): DIO mice have a 
significantly higher Ki-67 protein expression level (presented as Ki-67 signal area ratio to 
nucleus area) comparing to control group (Figure 4 I). This result suggests that DIO mice have a 
higher proliferative activity level comparing to CON mice, which indicating that DIO has 
















The current study utilized DIO in CBA mice to demonstrate that DIO downregulated the 
expression of genes involved in Wnt signaling pathway and the downstream target genes in 
colon.  This suppression of Wnt signaling was confirmed by immunofluorescent staining, which 
showed that the accumulation of -catenin protein along colon crypts was lowered in DIO mice 
comparing to the control mice.  
 
DIO SUPPRESSES WNT SIGNALING EXPRESSION IN SEVERAL ORGANS 
The current study suggests that DIO suppressed the Wnt signaling pathway in the distal 
colon of male mice. Despite the direct influence from DIO on mRNA expression of Wnt ligands 
such as Wnt2, Wnt5a and Wnt7b, in this current study we also found significant upregulations of 
Sfrp2 and Sfrp5 mRNA expression in colon of mice induced by DIO. In general, both Sfrp2 and 
Sfrp5 are linked tightly with Wnt signaling pathway function mostly as antagonist (54-59). 
Nevertheless, Sfrp5 is also proved to be an anti-inflammatory adipokine that modulates 
metabolic dysfunction in obesity (60). However, the role Sfrp2 plays in Wnt signaling is 
somehow controversial: one study found that Sfrp2 serves as a Wnt agonist in lung cancer cells 
(61), however, another study claiming that it is the silencing of Sfrp2 induces Wnt signaling in 
cervical cancer cell lines (62). Based on the results obtained in this current study and what has 
been concluded in previous study (63), it is reasonable to assume that Sfrp2 and Sfrp5 serve as 
Wnt signaling antagonists in distal colon of mice, and the aberrant expression of these genes 
contributes to the inhibition of Wnt signaling, which further influence lipid metabolism and 




DIFFERENTIAL LOCALIZATION OF -CATENIN PLAYS SIGNIFICANT ROLE IN 
PROGNOSIS OF COLORECTAL CARCINOGENESIS 
This current study has two unique discoveries regarding -catenin localization: 1) 
Compared to control mice, DIO mice had less -catenin protein expression on their muscularis 
mucosae and submucosa layers; 2) Compared to control mice, DIO mice had less nucleus -
catenin accumulation along the crypt. Furthermore, DIO mice express -catenin more on the 
bottom of the crypt (close to submucosa layer), while control mice express -catenin more on the 
top of crypt (close to lumen). 
Previous research has established a significant correlation between -catenin 
translocation and colorectal carcinogenesis and a potential correlation between -catenin 
translocation and lymph node metastasis, colorectal cancer patient survival and colorectal cancer 
prognosis, indicating that the localization of -catenin could be a crucial indicator for colorectal 
cancer (64-72). Particularly, one study discovered that in most colorectal tumor samples, 
increased -catenin protein level were found in the cytosol and/or membrane compartment 
comparing to nucleus (73), which is similar to what was observed in DIO mice in this current 
study. 
However, most studies discussed the change of -catenin protein expression on 
subcellular level, especially within nucleus, without mentioning changes happened on 
membranous and cytosol accumulation of -catenin, or changes of -catenin protein expression 
level along colonic crypt. Furthermore, most of the findings were established based on colorectal 
cancer model rather than DIO model. Therefore, the findings brought up by this current study are 
unique and important to justify the clinical significance of investigation on DIO-triggered, 
different spatial localization of -catenin in colon. Considering the link between Wnt signaling 
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and colorectal cancer, a potential application of this information would be, to use the spatial 
localization of -catenin as an indicator to detect the abnormality of colon during early stage of 
carcinogenesis, rather than the protein expression. However, to establish a complete conclusion 
on this topic, a fully investigation using a 3D model is required for further research. 
Additionally, the connection among DIO, -catenin and Ki-67 expression remains 
unclear at this point, however, it is demonstrated by previous studies that the expression level of 
Ki-67 is correlated to the expression of Cyclin D1, and they may be used together as a marker for 
carcinogenesis and active cell proliferation(74-78). In our current study, we observed both 
increased Ki-67 protein expression and Cyclin D1 mRNA expression in DIO mice, which is 
consistent with previous studies and further confirmed a higher proliferative activity is promoted 
by DIO in colon cells.  
 
MECHANISMS THROUGH WHICH SUPPRESSED -CATENIN REGULATES CELL 
CYCLE 
In this current study, the mRNA expression of several genes that play significant role in 
cell cycle were selected and examined, among which c-Myc, Raf-1, Axin1 and p21 were found 
significantly downregulated in DIO mice while CyclinD1 was upregulated. 
The downregulation of c-Myc is expected, as c-Myc is the target gene in Wnt pathway, 
and DIO suppresses Wnt signaling. c-Myc has been reported to play crucial role in cell 
proliferation and differentiation through the following mechanisms:  c-Myc revokes the 
transcription of cell cycle checkpoint genes such as GADD45 and GADD153; inhibits the 
function of cyclin-dependent kinase (CDK) inhibitors; activates Cyclin D1, Cyclin D2, Cyclin E1 
and Cyclin A2 therefore promotes cell cycle progression (79). Hence, the downregulation of c-
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Myc caused by suppressed Wnt signaling from DIO will lead to less expression of CDK subunits 
and elevated expression of CDK inhibitors (80), which consequently overcomes cell-cycle 
arrests and causes cells to withdraw from the G1 phase.  
On the other hand, previous study implied that activated Wnt/-catenin signaling 
promotes expression of p21 in mesenchymal stem cells (MSCs) to regulate cellular development 
(81). Here, we confirmed that with a suppressed Wnt/-catenin signaling from DIO, the 
expression of p21 decreased, and this decrease is likely to cause increased G2 phase arrest in cell 
cycle and therefore increase apoptosis (82). Additionally, a downregulated of Raf-1 was detected 
in the current study in DIO mice. Raf-1, in general, is believed to play as pro-survival 
antiapoptotic factors in cell cycle (83). Raf-1 is linked to -catenin in breast tumorigenesis, 
together they are responsible for the expansion of tumor (84). However, no evidence was found 
to demonstrate the interaction between Raf-1 and -catenin in colon. One potential mechanism 
linking them together is through extracellular signal-regulated kinase (ERK) pathway in colon, 
because literature evidence suggests that -catenin as well as Axin1 and APC are involved in the 
activation of Ras-ERK pathway, which controls Raf-1 expression (85, 86). Further research is 
necessary in order to fully investigate the connection between these pathways. 
Cyclin D1 is a well-established target gene of Wnt signaling (87, 88), and controversially 
was observed upregulated in DIO mice. The potential explanation here could be that the 
decreased expression of p21, a main CDK inhibitor, caused a positive influence on expression of 
CyclinD1 through p53-dependent pathway (89), which is stronger to overcome the negative 
influence brought by suppressed Wnt signaling. Furthermore, DIO was previously found to 
induce tumor growth by upregulating protein expression level of CyclinD1 (90). Another 
research done in 2012 also suggests that DIO animal showed a higher protein level expression of 
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CyclinD1 in colon, which then be concluded as a possible mechanism through which DIO 
facilitate colon tumor formation (91). 
 
CONCLUSION 
In this current study, we proposed a schematic presented in Figure 5 showing a potential 
mechanism how DIO downregulates Wnt signaling pathway and regulate cell proliferation in 
colon. First, DIO suppresses Wnt signaling activators - Wnt2, Wnt7b and Wnt5a while 
upregulates Wnt antagonist - Sfrp2 and Sfrp5 expression, which consequently impairs cytosolic 
Axin1-APC interaction in the destruction complex that mediates Wnt signaling transduction, 
thus, leads to downregulated -catenin expression on both gene and protein level. This DIO-
induced downregulation of -catenin further triggers downregulated cMyc, p21 and Raf-1 
expression, together they contribute to the upregulation of downstream CyclinD1 expression, 
which is correlated to the expression of Ki-67, indicating an elevated cell proliferation activity in 
colon.  
Although the detailed mechanism behind which diet-induced-obesity regulates cell 
proliferation through interactions among several signaling, including Wnt, remains unclear, 
findings of this current study still provides evidence for the connection between diet-induced-
obesity and disrupted Wnt signaling, and proves that proliferative activity is influenced 
consequently. Therefore, it is crucial to take Wnt signaling as well as -catenin expression and 
localization into consideration when examine patients during clinical trials, because it could be 



















Table 1. mRNA Expression of Genes Involved in Several Pathways 
Pathway Identification Gene Control DIO Fold Change in DIO P-value 
Non-canonical Wnt Signaling WNT5a 8.59±2.66 3.04±0.50 -0.65 0.0367 
Canonical Wnt Signaling 
SFRP2 74.04±16.04 200.23±56.77 1.7 0.032 
SFRP5 2.59±0.40 7.38±2.41 1.85 0.0425 
APC 1.07±0.41 0.70±0.19 -0.35 0.2251 
WNT2 4.53±1.42 2.58±0.83 -0.43 0.1354 
WNT7b 23.56±5.79 11.02±3.67 -0.53 0.048 
AXIN1 2.58±0.81 0.99±0.29 -0.62 0.0492 
CTNNB1 0.88±0.29 0.29±0.06 -0.67 0.0428 
Cell Cycle/Proliferation/Apoptosis 
CYCLIN D1 13.80±3.98 42.67±10.05 2.09 0.0114 
C-MYC 4.10±1.36 1.49±0.39 -0.64 0.0499 
P21 14.92±5.53 3.91±0.80 -0.74 0.0429 
RAF1 0.07±0.03 0.01±0.003 -0.86 0.0348 
Endocytic Pathways  AGAP2 2.71±0.87 2.82±0.56 0.04 0.4598 
Cell Invasion PKP2 0.57±0.26 0.78±0.18 0.37 0.2636 
Table 1. mRNA expression of -catenin and genes in other selected signaling pathways in the colon of male mice in either control or 
DIO group. Quantity results are presented as normalized ratio to reference genes in mean±SEM (n=12); An increased expression of specific 
gene in DIO leads to positive fold change while decreased expression leads to negative fold change; fold change is calculated by subtracting 
CON gene expression from DIO gene expression, then divided by CON gene expression; p-value indicates the significance on gene expression 






Figure 1. Average food intake (in kcal) and body composition change between control and DIO 
mice during experiment period.  
* 
* * * 
* 
* 
* * * * 
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Figure 1 (cont.) 
A: Meaningful change of mean body weight between control and DIO group was observed starting from 
the 4th week of experiment, and the significance grew as experiment went on until the end of the trial;  
B: Mean food intake per animal per day in kcal was significantly different at the first week of the experiment 
and remains different through the experimental period until the end of the trial;  
C: The mean body fat percentage measured by MRI between control and DIO group was identical at the 
beginning of the experiment, however, after 4 weeks, a significant difference was observed, and the 























Figure 2. Histological analysis suggests no diet effect on colonic structure of mice between control 
and DIO group.  
A: H&E straining was conducted in mice from both control and DIO group to conduct histological analysis 
and observe colonic crypt structures in detail. (SM: Submucosa MM: Muscularis mucosae)  
B: Independent t-test assuming equal variance was performed to analyze the mean crypt length of colon 
tissue from mice in control or DIO group (5 measurements per animal, n=12 per group). The results are 
presented in mean±SEM (μm). No significant difference was detected, suggesting that diet does not affect 






























Figure 3. Confocal immunofluorescent analysis of mouse colon using β-Catenin (green; A, E, I, 
M), actin filament (red; C, G, K, O), DRAQ5 pseudo-color that marks DNA (blue; B, F, J, N) and 
merged pictures (D, H, L, P) to visualize -catenin accumulation and localization in 20X and 63X 
Oil magnification. (SM: Submucosa MM: Muscularis mucosae) 
A-H: Under 20X Oil magnification, intense green signal suggesting stronger β-Catenin accumulation on 
submucosa and at the simple columnar epithelium in colon tissue from CON and DIO mice;  
I-P: Under 63X magnification, more intense green signal from β-Catenin accumulation was observed in 
colon tissue from DIO mice, especially at the bottom part of crypt near the submucosa, indicating the change 
of β-Catenin accumulation between CON and DIO mice happened not only on subcellular level but also on 
cellular level;  
Q: Independent t-test assuming unequal variance was performed to analyze the relative level of β-Catenin 
nuclear accumulation in colon tissue from DIO and CON mice (22 measurements per group). The results 
are presented as β-Catenin immunofluorescence signal intensity ratio to nucleus volume (µm3), in the form 
of Mean±SEM. Significant difference was detected, suggesting that diet has strong effect on the β-Catenin 








Figure 4. Confocal immunofluorescent analysis of mouse colon using Ki-67 (green; A and E), actin 
filament (red; C and G) and DRAQ5 pseudocolor that marks DNA (blue; B and F) and merged 
pictures (D and H) to visualize Ki-67 expression and localization in 20X magnification.  
A-D: weak green signal suggesting low Ki-67 expression on both submucosa and on the crypt in colon 




Figure 4 (cont.) 
E-H: intense green signal suggesting high Ki-67 expression on both submucosa and along the crypt in colon 
tissue from DIO mice;  
I: Independent t-test assuming unequal variance was performed to analyze the relative level of Ki-67 
expression in colon tissue from DIO and CON mice (5 measurements per group). The results are presented 
as Ki-67 immunofluorescence signal area (µm3) ratio to nucleus signal area (µm3), in the form of 
Mean±SEM. Significant difference was detected, suggesting that diet has strong effect on the Ki-67 









































Figure 5. Schematic of genes examined in the current study that involved in the potential mechanisms 
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Diet Formula Control  High Fat 
 gm% kcal%  gm% kcal% 
Protein 19.2 20  24 20 
Carbohydrate 67.3 70  41 35 
Fat 4.3 10  24 45 
Total  100   100 
kcal/gm 3.85   4.73  
      
 gm kcal  gm kcal 
Casein, 30 Mesh 200 800  200 800 
L-Cystine 3 12  3 12 
Corn Starch 452.2 1808.8  72.8 291 
Maltodextrin 10 75 300  100 400 
Sucrose 172.8 691.2  172.8 691 
Cellulose, BW200 50 0  50 0 
Soybean Oil 25 225  25 225 
Lard 20 180  177.5 1598 
Mineral Mix S10026 10 0  10 0 
DiCalcium Phosphate 13 0  13 0 
Calcium Carbonate 5.5 0  5.5 0 
Potassium Citrate, 1 H2O 16.5 0  16.5 0 
Vitamin Mix V10001 10 40  10 40 
Choline Bitartrate 2 0  2 0 
FD&C Yellow Dye#5 0.04 0  N/A N/A 
FD&C Red Dye#40 0.01 0  0.05 0 
Total 1055.05 4057  858.15 4057 
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*The qPCR amplification efficiency is calculated based on the slope of the standard curve 
(https://www.lifetechnologies.com/us/en/home/brands/thermo-scientific/molecular-biology/molecular-biology-
learning-center/molecular-biology-resource-library/thermo-scientific-web-tools/qpcr-efficiency-
calculator.html). Slopes between -3.1 and -3.6 giving reaction efficiencies between 90 and 120% are typically 
acceptable. 
Supplementary Table 2. List of Primers   
Gene Name Ensembl Transcription ID Position Sequence 
Amplification 
Efficiency* 
mL7a ENSMUST000001028986 Forward +176 5'-AACTTCGGCATTGGACAGGACA-3' 100.521% 
  Reverse +289 5'-TTTGAGCCGCTTGTAGAGGATAGC-3'  
mActB ENSMUST00000102507.9 Forward +153 5'-GAT GCT CCC CGG GCT GTA TT-3' 107.079% 
  Reverse +219 5'-TTC CCA CCA TCA CAC CCT GG-3'  
mGADPH ENSMUSE00001143324 Forward +65 5'-TTG ATG AGT ATG AAG TGC CC-3' 98.744% 
  Reverse +153 5'-GCT GGA GTA GCC ATT CTA AT-3'  
mP21 ENSMUST00000023829 Forward +32 5'-CAGAGTCTAGGGGAATTGGAGTCAG-3' 104.066% 
  Reverse +97 5'-CCTGTGGCTCTGAATGTCTGGA-3'  
mWnt5a ENSMUST00000112272 Forward +555 5'-GCTGCGGAGACAACATCGACTATG-3' 100.741% 
  Reverse +621 5'-TCCCTTTCTCTAGCGTCCACGAAC-3'  
mc-Myc ENSMUST00000188482 Forward +1369 5'-CCAGCAGCGACTCTGAAGAAGAGC-3' 102.196% 
  Reverse +1459 5'-TCCGACCTCTTGGCAGGGGTTT-3'  
mSfrp2 ENSMUST00000029625 Forward +491 5'-CACCAAGAAGTTCCTGTGCTCGC-3 92.928% 
  Reverse +564 5'-GACACGGCTGGATGGTCTCATCT-3’  
mSfrp5 ENSMUST00000018966 Forward +807 5'-GCCTCATGGAACAGATGTG-3' 97.896% 
  Reverse +884 5'-GGTCCCCGTTGTCTATCTT-3'  
mWnt2 ENSMUST00000010941 Forward +803 5'-CGTGCCTTTGTAGATGCCA-3' 98.379% 
  Reverse +895 5'-CTTTACAGCCTTCCTTCCAGC-3'  
mCyclinD1 ENSMUST00000060455 Forward +254 5’-GAGCGTTACCAGAACCTGTCTCCA-3’ 101.111% 
  Reverse +319 5’-AAGTGCGTTGTCAGAACAGTGGCT-3’  
mWnt7b ENSMUST00000023015 Forward +878 5'-CCGTGAGATCAAAAAGAACGCCAGG-3' 100.106% 
  Reverse +945 5'-GAACCTTTCTGCCCGCCTCATTGTT-3'  
mRAF1 ENSMUST00000000451 Forward +1270 5'-CGAAGTCACAGTGAATCAGCCTCA-3' 96.041% 
  Reverse +1333 5'-TTGGACTCAGGTTGTTTGGGCT-3'  
mCTNNB1 ENSMUST00000007130.14 Forward +980 5'-CTTTAAGTCTGGTGGCATCC-3' 93.86% 
  Reverse +1058 5'-CGTGATGGCGTAGAACAGTA-3'  
mAxin 1 ENSMUST00000074370.9 Forward +1647F 5’-GGCTGAAGAAAAGTTGGAGGAACG-3’ 92.726% 
  Reverse+ 1715R 5’-ATTTCACCATCCTCCCCTTCTTCC-3’  
mAPC ENSMUST00000079362.11 Forward +1171F 5’-CCAGTGTTTTGAGTTCTAGCGGCA-3’ 96.51% 
  Reverse +1239R 5’-CCTTTGTCCCCAGATGACTTGTCA-3’  
